SHENZHEN INT'L (00152) issues a profit warning, expecting a loss attributable to shareholders of approximately HKD 190 million to 240 million for the first half of the year.
Shenzhen International (00152) announced that the group expects to incur a loss attributable to shareholders of approximately HKD 190 million to HKD 240 million for the six months ending June 30, 2026, compared to a profit attributable to shareholders of approximately HKD 490 million for the same period last year.
SHENZHEN INT'L (00152) announced that the group expects to record a loss attributable to shareholders ranging from approximately HK$190 million to HK$240 million for the six months ending June 30, 2026, compared to a profit attributable to shareholders of approximately HK$490 million in the same period last year.
The group anticipates a shift from profit to loss during this period, primarily influenced by the following factors: (1) fair value losses on certain investment properties held by the group; (2) a joint venture in which the group holds a 50% interest shifting from profit to loss during this period; (3) the group has not recorded any land consolidation and development profits or income related to asset injection funds during this period. These factors are expected not to impact the group's operational cash flow, and the group's overall financial and business conditions remain healthy.
Related Articles

INKEVERSE (03700) issues a profit warning, expecting that net profit for the first half of the year will decline by more than 30.0% year-on-year.

JD HEALTH (06618) launched 65 new drugs in the first half of the year, leading the industry, with pharmaceutical sales maintaining the top position in the sector.
.png)
Jl Mag Rare-Earth (06680): Termination of subscription for shares of Australian-listed rare earth company Hastings.
INKEVERSE (03700) issues a profit warning, expecting that net profit for the first half of the year will decline by more than 30.0% year-on-year.

JD HEALTH (06618) launched 65 new drugs in the first half of the year, leading the industry, with pharmaceutical sales maintaining the top position in the sector.

Jl Mag Rare-Earth (06680): Termination of subscription for shares of Australian-listed rare earth company Hastings.
.png)
RECOMMEND





